M, O., N, U., JJJ, G., AGJ, v. R., IAM, M., S, B., . . . SC, L. (2026). Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02). Breast (Edinburgh, Scotland), 87, 104749. https://doi.org/10.1016/j.breast.2026.104749
Chicago Style (17th ed.) CitationM, Opdam, et al. "Immunohistochemical Biomarkers to Predict Adjuvant Chemotherapy Response in Patients with Early Breast Cancer in the MATADOR Trial (BOOG 2005-02)." Breast (Edinburgh, Scotland) 87 (2026): 104749. https://doi.org/10.1016/j.breast.2026.104749.
MLA (9th ed.) CitationM, Opdam, et al. "Immunohistochemical Biomarkers to Predict Adjuvant Chemotherapy Response in Patients with Early Breast Cancer in the MATADOR Trial (BOOG 2005-02)." Breast (Edinburgh, Scotland), vol. 87, 2026, p. 104749, https://doi.org/10.1016/j.breast.2026.104749.